Virology
Moderna launches human trial for mRNA flu vaccine
Moderna Therapeutics is trialing an mRNA flu vaccine in humans and developing one to protect against seasonal influenza and COVID-19.
Oxford launches HIV vaccine trial
The University of Oxford’s newly launched HIV vaccine trial will test a unique approach to protecting people against the AIDS-causing virus.
“LEGO-like” vaccine protects mice from COVID, SARS, MERS, and variants
Using a “chimeric” spike protein, researchers have immunized mice against multiple types of coronaviruses with one shot.
We may have a new ally in the fight against dengue fever
A large trial has provided the best evidence yet that infecting mosquitoes with Wolbachia can help reduce dengue infections.
A virus "chimera" reveals new dengue targets
Using a flavivirus that only infects insects, Australian researchers can safely study more dangerous viruses.
Did the flu lose diversity during the pandemic?
After a record-low flu season, an entire clade of flu may be gone. If so, making vaccines may have become easier.
Inhaled CRISPR treatment tackles COVID-19, flu
An inhaled CRISPR treatment can be easily tweaked to attack a variety of viruses, from the one that causes the flu to the coronavirus behind COVID-19.
Predicting your protection against COVID-19
Australian researchers have found an immune response measurement they believe can predict protection against COVID-19.
Pfizer is testing a coronavirus antiviral
Pfizer is testing a new coronavirus antiviral that has stopped SARs-CoV-2 from replicating in the lab in humans.
Oxford launches COVID reinfection study
To try and understand the immune response to SARS-CoV-2, including the threat of COVID reinfection, the University of Oxford will purposely infect volunteers.